Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Cardiovascular Disorders » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
_Cancer Research Journal - This journal ceased publication after 4#4 (2010). Back Issues are available.
$195.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Cardiomyopathies: Causes, Effects and Treatment
02.Progress in Cardiac Arrhythmia Research
03.Cardiovascular Diseases and Liver Transplantation
04.Cholesterol in Atherosclerosis and Coronary Heart Disease
05.Heart Disease in Women
06.Advances in Cardiovascular Research, Volume 1
07.Heart Disease in Men
08.Molecular Mechanisms of Tobacco-Induced Diseases
09.Congenital Heart Defects: Etiology, Diagnosis and Treatment
10.Coronary Artery Disease, Cardiac Arrest and Bypass Surgery: Risk Factors, Health Effects and Outcomes
Notifications more
NotificationsNotify me of updates to Angiotensin Converting Enzyme Inhibitors
Tell A Friend
 
Tell someone you know about this product.
Angiotensin Converting Enzyme Inhibitors
Retail Price: $175.00
10% Online Discount
You Pay:

$157.50
Editors: Anne N. DeBrue
Book Description:
Angiotensin II is a very potent chemical that causes the muscles surrounding blood vessels to contract, thereby narrowing the vessels. The narrowing of the vessels increases the pressure within the vessels causing high blood pressure (hypertension). Angiotensin II is formed from angiotensin I in the blood by the enzyme angiotensin converting enzyme (ACE). ACE inhibitors are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II. As a result, the blood vessels enlarge or dilate, and blood pressure is reduced. This lower blood pressure makes it easier for the heart to pump blood and can improve the function of a failing heart. In addition, the progression of kidney disease due to high blood pressure or diabetes is slowed.
ACE inhibitors are used for controlling blood pressure, treating heart failure, preventing strokes, and preventing kidney damage in people with hypertension or diabetes. They also improve survival after heart attacks. Because they prevent early death resulting from hypertension, heart failure or heart attacks, ACE inhibitors are one of the most important group of drugs. This new book presents important research in this field.

Table of Contents:
Preface

1. Angiotensin Converting Enzyme Inhibitors
(Macaulay A. C. Onuigbo, Assistant Professor of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, Nnonyelum T. C. Onuigbo, Architect/Data Base Analysrt/Programmer, Information Technologies, NTec Solutions LLC, Eau Claire, WI) pp. 1-41

2. Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature and Case Report
(Hiromichi Yoshida, Dept. of Internal Medicine, San-ai Memorial Hospital, Chiba, Japan, Shigeru Hasegawa, Dept. of Nephrology, Chiba Social Insurance Hospital, Chiba, Japan, Yasubumi Irie, Dept. of Internal Medicine, San-ai Memorial Hospital, Chiba, Japan) pp. 43-62

3. Plant-Derived Substances as ACE inhibitors
(Ingrid A-L Persson, Karin Persson, Dept. of Medicinal and Health Sciences, Divisioin of Drug Research/Pharmacology, Faculty of Health Sciences, Linkoping Univ., Sweden) pp. 63-93

4. The Proper Use of Angiotensin-Covering Enzyme Inhibitors in Patients with Chronic Kidney Disease
(Hiroshi Nonoguchi, Division of Kidney and Dialysis, Dept. of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, Takeaki Inoue, Dept. of Nephrology, Kumamoto Univ. Graduate School of Medicine Sciences, Kumamoto, Japan, Yushi Nakayama, Dept. of Nephrology, Kumamoto Univ. Graduate School of Medicine Sciences, Kumamoto, Japan, Yuichiro Izumi, Dept. of Nephrology, Kumamoto Univ. Graduate School of Medicine Sciences, Kumamoto, Japan, Takeshi Nakanishi, Division of Kidney and Dialysis, Dept. of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan) pp. 95-112

5. Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function
(Fadi Alqaisi, Mouaz H. Al-Mallah, FACC, Henry Ford Heart and Vascular Inst., Detroit, MI) pp. 113-128

6. Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibitor
(George S. Stergiou, Efthimia G. Nasothimiou, Hypertension Center, Third Univ. Dept. of Medicine, Sotiria Hospital, Athens, Greece) pp. 129-146

7. Angiotensin-Converting Enzyme Inhibitors in Patients with
Bilateral Atherosclerotic Renal Artery Stenosis
(Sarabjeet Singh, Bipin Thapa, Roopashree Prabhu, Rohit Arora, Sandeep Khosla, Section of Cardiology, Department of Medicine, Rosalind Franklin University of Medicine & Science/ The Chicago Medical School, North Chicago, and Mount Sinai Hospital, Chicago, Illinois) pp. 147-161

8. Angiotensin Converting Enzyme Inhibitors in Renal Disease
(Nicolas Roberto Robles, Unidad de Hipertension, Servicio de Nefrologia, Hospital Infanta Cristina, Badajoz, Spain) pp. 163-184

9. Kallikrein-Kinin Pathways in Mediate the Hypotensive Action of Angiotensin Converting Enzyme (ACE) Inhibitors
(J. N. Sharma, Dept. of Applied Therapeutics, Faculty of Pharmacy, Health Sciences Center, Kuwaut Univ. Safat, Kuwait) pp. 185-198

10. Angiotensin Converting Enzyme Inhibitors: Improving Utilization and Adherence
(Micah L. Thorp, Lake Road Nephrology Center, Kaiser Kidney Program, Kaiser Permanente Northwest, Milwaukie, Ore) pp. 199-210

11. Angiotensin Blockade in Pediatric Chronic Kidney Disease
(Lavjay Butani, Section of Pediatric Nephrology, Univ. of California Davis Medical Center, Sacramento, CA) pp. 211-217

Index pp.219-238

   Binding: Hardcover
   Pub. Date: 2011 - 2nd quarter
   Pages: 238.pp
   ISBN: 978-1-60692-619-2
   Status: AV
  
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
  
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Angiotensin Converting Enzyme Inhibitors